e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate
van Diemen C. C., Postma D. S., Aulchenko Y. S., Snijders P. J. L. M., Oostra B. A., van Duijn C. M., Boezen H. M.
Source:
Eur Respir J 2010; 35: 768-775
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
van Diemen C. C., Postma D. S., Aulchenko Y. S., Snijders P. J. L. M., Oostra B. A., van Duijn C. M., Boezen H. M.. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate. Eur Respir J 2010; 35: 768-775
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Novel strategy to identify genetic risk factors for COPD severity: genetically isolated populations
Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD
Year: 2008
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation
Source: Eur Respir J 2011; 38: 749-751
Year: 2011
Identification of novel rare genetic variants associated with COPD in the general population
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018
Individual susceptibility to environmental risks
Source: Annual Congress 2007 - Individual susceptibility to environmental risks
Year: 2007
Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017
A genome-wide association study on the risk variations for susceptibility to early COPD
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity
Source: Eur Respir J, 58 (4) 2100199; 10.1183/13993003.00199-2021
Year: 2021
Genetic risk for covid-19 outcomes in COPD
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis?
Source: Eur Respir J 2016; 48: 1271-1273
Year: 2016
Late Breaking Abstract: A genome-wide association study identifies variants at 12q13.3-q14.1 as genetic risk factors for sarcoidosis
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Mapping IPF helps identify geographic regions at higher risk for disease development
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
Known and emerging risk factors for asthma development: is prevention possible?
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015
Genetic typing of bronchial asthma afflicted people according to polymorphous genes for the purpose of disease progress risk factors detection
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Genetic determinants of lung function in COPD: A genome-wide association study
Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD
Year: 2010
Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Genetic heterogeneity of asthma phenotypes identified by a clustering approach
Source: Eur Respir J 2014; 43: 439-452
Year: 2013
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Prevalence of COPD in the general population according to cardiovascular risk factors
Source: Eur Respir J 2007; 30: Suppl. 51, 778s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept